» Articles » PMID: 15678170

An in Vitro Method to Select Malignant Cells from Surgical Biopsies of Breast Cancer Patients

Overview
Publisher Biomed Central
Date 2005 Jan 29
PMID 15678170
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

To date, breast cancer (BC) research is mainly studied with cell lines. These cells were passaged multiple times, acquiring phenotypes, additional mutations and epigenetic changes. These changes make the passaged cell lines different from the original malignancy. Thus cell lines, although useful as models could be improved with additional studies with primary BC. It is difficult to obtain malignant cells from breast tissues without contamination from surrounding healthy cells. Selection and expansion of malignant cells from surgical tissues have proved to be daunting tasks. This study describes a reliable and reproducible method for isolating and expanding malignant cells from surgical breast tissues. The method uses co-cultures with BM stroma to select for the cancer cells while the healthy cells undergo rapid cell death. Studies are described to show the cloning efficiencies and sensitivity of the method using surgical samples of varying sizes, different stages of BC, and samples from needle biopsies.

Citing Articles

Cell specific variation in viability in suspension in in vitro Poiseuille flow conditions.

Connolly S, Newport D, McGourty K Sci Rep. 2021; 11(1):13997.

PMID: 34234155 PMC: 8263586. DOI: 10.1038/s41598-021-91865-1.


Mesenchymal stem cells in early entry of breast cancer into bone marrow.

Corcoran K, Trzaska K, Fernandes H, Bryan M, Taborga M, Srinivas V PLoS One. 2008; 3(6):e2563.

PMID: 18575622 PMC: 2430536. DOI: 10.1371/journal.pone.0002563.


Role of human HGFIN/nmb in breast cancer.

Metz R, Patel P, Hameed M, Bryan M, Rameshwar P Breast Cancer Res. 2007; 9(5):R58.

PMID: 17845721 PMC: 2242655. DOI: 10.1186/bcr1764.

References
1.
Moore K, Ema H, Lemischka I . In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood. 1997; 89(12):4337-47. View

2.
Muller A, Homey B, Soto H, Ge N, CATRON D, Buchanan M . Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001; 410(6824):50-6. DOI: 10.1038/35065016. View

3.
Kato M, Kitayama J, Kazama S, Nagawa H . Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res. 2003; 5(5):R144-50. PMC: 314431. DOI: 10.1186/bcr627. View

4.
Mansi J, Berger U, McDonnell T, Pople A, Rayter Z, Gazet J . The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol. 1989; 7(4):445-9. DOI: 10.1200/JCO.1989.7.4.445. View

5.
Gluck S . Autologous transplantation for patients with advanced breast cancer with emphasis on bony metastasis. Can J Oncol. 1995; 5 Suppl 1:58-62. View